Athersys (NASDAQ:ATHX) Receives New Coverage from Analysts at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX) in a report released on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

Shares of ATHX opened at $0.00 on Friday. The stock’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.02. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99. The firm has a market capitalization of $271,563.60, a PE ratio of 0.00 and a beta of -0.90.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.